Family Management Corp Seagen Inc. Transaction History

Family Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $140,800 - $232,053	-1,294 Reduced 6.64%	18,198 $3.22 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $11,482 - $15,153	-96 Reduced 0.49%	19,492 $2.81 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $8,696 - $11,642	61 Added 0.31%	19,588 $3.03 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $78,774 - $93,910	-553 Reduced 2.75%	19,527 $3.32 Million
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $234,228 - $279,347	1,734 Added 9.45%	20,080 $3.17 Million

Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $127,609 - $177,062	928 Added 5.33%	18,346 $2.55 Million
Q4 2020 Feb 10, 2021	BUY	$164.63 - $211.93 $2.87 Million - $3.69 Million	17,418 New	17,418 $3.05 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

Stay updated on Family Management Corp with notifications on news.